Clinical Trial Update: Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm [Phase 1, Phase 2]

View source ↗

Summary

A randomized clinical trial exploring modulation of GABA-A receptors using a flumazenil arm in Parkinson disease has completed Phase 1 and Phase 2 with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Flumazenil (flumazenil)

Snippet

Sponsor: University of Michigan | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-06-29